Compounds > bisoprolol

bisoprolol and venlafaxine hydrochloride

bisoprolol has been researched along with venlafaxine hydrochloride in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Falter, T; Haen, E; Hefner, G; Hiemke, C; Shams, ME; Unterecker, S; Wolf, M1
Tchernev, G1
Ivanov, L; Lozev, I; Tchernev, G1

Other Studies

3 other study(ies) available for bisoprolol and venlafaxine hydrochloride

ArticleYear
Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey.
    Journal of neural transmission (Vienna, Austria : 1996), 2015, Volume: 122, Issue:11

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Bisoprolol; Butyrophenones; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Pharmaceutical; Drug Monitoring; Female; Humans; Male; Metoprolol; Middle Aged; Retrospective Studies; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult

2015
NITROSOGENESIS OF SKIN CANCER: THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAR
    Georgian medical news, 2023, Issue:339

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Bisoprolol; Calcium Channel Blockers; Enalapril; Humans; Incidence; Losartan; Metformin; Paroxetine; Perindopril; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Skin Neoplasms; Valsartan; Venlafaxine Hydrochloride

2023
MORPHEAFORM BCC OF ALA NASI: A SUCCESSFUL DERMATOSURGICAL APPROACH BY TRANSPOSITION FLAP FROM THE ADJACENT AREA. CONTAMINATION OF VENLAFAXINE, BISOPROLOL AND OLANZAPINE WITH NITROSAMINES/NDSRIS: THE MOST LIKELY CAUSE OF SKIN CANCER DEVELOPMENT AND PROGRES
    Georgian medical news, 2023, Issue:342

    Topics: Aged, 80 and over; Bisoprolol; Carcinogens; Humans; Nitrosamines; Olanzapine; Skin Neoplasms; Venlafaxine Hydrochloride

2023